First Trust Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

First Trust Advisors’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-3,776	Closed	-$437K	–	2550
2018 Q2	$437K	Sell	3,776 -6,806	-64%	-$748K	﹤0.01%	2198
2018 Q1	$1.04M	Buy	10,582 +4,100	+63%	+$415K	﹤0.01%	1779
2017 Q4	$679K	Buy	+6,482	New	+$712K	﹤0.01%	1994
2016 Q4	–	Sell	-3,103	Closed	-$343K	–	2524
2016 Q3	$343K	Buy	+3,103	New	+$411K	﹤0.01%	2107
2015 Q4	–	Sell	-2,176	Closed	-$311K	–	2318
2015 Q3	$311K	Buy	+2,176	New	+$304K	﹤0.01%	2083

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

FCH

Freestone Capital Holdings Seattle, Washington $3.3B AUM 21.14% 1-Year Est. Return

First Trust Advisors's TARO Position: Q3 2018 in Review

First Trust Advisors sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2018, closing a stake of 3,776 shares — an estimated $437K sold.

First Trust Advisors first reported a position in TARO in Q3 2015 and held it in 5 quarters. The position peaked at $1.04M in Q1 2018. 114 funds tracked by Wall St. Rank hold TARO as of Q3 2018.

First Trust Advisors reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2018 after selling out during the quarter.
First Trust Advisors sold 3,776 Taro Pharmaceutical Industries Ltd. shares in Q3 2018, an estimated $437K.
First Trust Advisors first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2015 and held it in 5 quarters.
First Trust Advisors's Taro Pharmaceutical Industries Ltd. position peaked at $1.04M in Q1 2018.
114 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2018.

Based on First Trust Advisors's 13F filing for Q3 2018, filed 25 Oct 2018.